FDAnews
www.fdanews.com/articles/197245-biom%C3%A9rieuxs-covid-19-antibody-tests-obtain-ce-mark
Needle.jpg

BioMérieux’s COVID-19 Antibody Tests Obtain CE Mark

May 22, 2020

BioMérieux has received CE mark certification for its VIDAS COVID-19 serology tests, which detect antibodies in the blood.

The in-vitro diagnostic company’s VIDAS anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG tests identify antibodies in patients exposed to the coronavirus. Both tests deliver results within a half hour, the company said.

Patients with antibodies likely were infected with the coronavirus at some point and may have developed some level of immunity.

View today's stories